Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

European Commission approves Kineret for the treatment of Still's disease

April 11, 2018

Novartis patents agents for tendon and/or ligament injuries

April 11, 2018

SELECT-COMPARE phase III study meets all primary and ranked secondary endpoints

April 10, 2018

Biogen and Samsung Bioepis cleared to commercialize Imraldi following AbbVie settlement

April 6, 2018

SpinalCyte reports data from phase I/II trial of CybroCell

April 4, 2018

Phase I trial of KA-34 is currently recruiting participants

April 4, 2018

Novel secretomes disclosed by researchers from Korea

April 4, 2018

Albert Einstein College of Medicine patents MSC-derived microvesicles

April 3, 2018

First patient enrolled in phase IIb trial of AmnioFix Injectable for the treatment of OA of the knee

March 29, 2018

Hernicore approved in Japan to treat lumbar disc herniation

March 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...